Statins and aortic stenosis progression: are biologic targets still an option?
Pai
Ramdas G
RG
Division of Cardiology, Keck School of Medicine/University of Southern California, 1510 San Pablo Street, #322, Los Angeles, CA 90033, USA. rpai@usc.edu
D001024:Aortic Valve Stenosis / Q000150:complications / Q000000981:diagnostic imaging / Q000517:prevention & control*; D000069059:Atorvastatin; D018450:Disease Progression; D015150:Echocardiography, Doppler; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy; D011758:Pyrroles / Q000627:therapeutic use*
D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D000069059:Atorvastatin